Endocrine Studies in Health and Disease
NCT00006073 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3090
Last updated 2017-10-06
Summary
This study will evaluate healthy normal volunteers and patients with a variety of endocrine disorders to 1) learn more about conditions that affect the endocrine glands (glands that secrete hormones) and 2) train physicians in endocrinology.
Patients with endocrine-related conditions and healthy volunteers of all ages may be eligible for this study.
All participants will have a physical examination medical and history. They may be required to provide blood, saliva or urine samples and undergo ultrasound (using sound waves) or magnetic resonance (using a magnetic field) imaging to visualize internal body structures.
Some healthy adult volunteers will have hormone-stimulating tests to assess endocrine function. These tests measure blood hormone levels before and after injection of a synthetic form of a hormone. A device called a heparin lock, through which the hormone is injected and the blood samples are collected, is placed in a vein in the arm or hand. Blood samples are drawn before the hormone is injected and at various intervals after the injection to measure levels of the hormone. These tests, which last from 1 to 3 hours, may include the following:
1. CRH stimulation test corticotropin-releasing hormone is given to test pituitary and adrenal gland function
2. ACTH stimulation test adrenocorticotrophic hormone is given to test adrenal gland function
3. LHRH stimulation test luteinizing hormone-releasing hormone is given to test pituitary gland function
4. TRH stimulation test thyroid-releasing hormone is given to test pituitary and thyroid gland function
5. GHRH stimulation test growth hormone releasing hormone is given to measure growth hormone levels.
An oral glucose tolerance test, which is similar to the stimulation tests, may also be done to measure blood glucose (sugar) and insulin levels after drinking a sugary liquid.
Healthy volunteers and patients with a hereditary endocrine disorder and their family members may also be asked to provide a blood sample for genetic studies of inherited endocrine disorders. Patients with endocrine-related disorders may be offered medical or surgical treatment for their disorder.
AcAccess http://turners.nichd.nih.gov/ for additional study publications.
Conditions
- Endocrine Diseases
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Margaret F Keil, C.R.N.P. · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-07-19
- Completion
- 2016-08-31
Countries
- United States
Study Locations
More Related Trials
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
NCT01862380 ·Status: UNKNOWN ·Phase: NA
-
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
NCT00136032 ·Status: COMPLETED ·Phase: NA
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Cushing's Disease Complications
NCT02568982 ·Status: COMPLETED
-
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
NCT00105352 ·Status: COMPLETED ·Phase: NA
-
Study and Monitoring of Multiple Endocrine Neoplasia Type 1
NCT03966612 ·Status: RECRUITING
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial
NCT00591760 ·Status: COMPLETED ·Phase: PHASE2
-
rhGH Therapy on Hepatic Drug Metabolism
NCT00458991 ·Status: COMPLETED
-
Growth Hormone in EB
NCT05390073 ·Status: UNKNOWN
-
Growth Hormone and Heart Failure
NCT00190359 ·Status: TERMINATED
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
NCT00004335 ·Status: COMPLETED
-
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
NCT00562796 ·Status: COMPLETED
-
Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
NCT04536662 ·Status: UNKNOWN ·Phase: PHASE4
-
Adipose Tissue and Serum Inflammation in GH Deficiency
NCT03500913 ·Status: COMPLETED
-
Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
NCT00489294 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
NCT00796783 ·Status: TERMINATED
-
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
NCT01052623 ·Status: UNKNOWN ·Phase: PHASE4
-
Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
NCT00720616 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
NCT03709381 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1